{
 "context": "The following article called 'Mid-Morning Market Update: Markets Open Higher; Lennar Tops Q3 Views' was published on 2015-09-22. The body of the article is as follows:\n    \nContent preferences Done \nFollowing the market opening Monday, the Dow traded up 0.63 percent to 16,488.07 while the NASDAQ climbed 0.65 percent to 4,858.57. The S&P also rose, gaining 0.56 percent to 1,969.05. \nLeading and Lagging Sectors \nIn trading on Monday, telecommunications services shares rose by 0.76 percent. Top gainers in the sector included Internet Gold Golden Lines Ltd (NASDAQ: IGLD ), up 7 percent, and Shenandoah Telecommunications Company (NASDAQ: SHEN ), up 4 percent. \nIn trading on Monday, basic materials shares were relative laggards, down on the day by about 0.03 percent. Meanwhile, top losers in the sector included HORSEHEAD HOLDING CORP. (NASDAQ: ZINC ), down 5 percent, and Compania de Minas Buenaventura SAA (ADR) (NYSE: BVN ), off 3 percent. \nTop Headline \nLennar Corporation (NYSE: LEN ) reported stronger-than-expected results for its fiscal third quarter on Monday. \nThe Miami, Florida-based company reported a quarterly profit of $223 million, or $0.96 per share, versus a year-ago profit of $177.8 million, or $0.78 per share. \nIts revenue rose 24 percent to $2.49 billion. However, analysts were expecting earnings of $0.79 per share on revenue of $2.42 billion. \nEquities Trading UP \nAtmel Corporation (NASDAQ: ATML ) shares shot up 15 percent to $8.33 after Dialog Semiconductor Plc (OTC: DLGNF ) announced its plans to acquire Atmel for around $4.6 billion. \nShares of CytRx Corporation (NASDAQ: CYTR ) got a boost, shooting up 7 percent to $3.05 after the company reported the publication of its positive global Phase 2b clinical trial results for soft tissue sarcoma in the peer-reviewed JAMA Oncology. \n  (NASDAQ: ALLT ) shares were also up, gaining 5 percent to $5.15 after the company reported   $8 million expansion order from a tier-1 operator. \nEquities Trading DOWN \nTribune Publishing Co (NYSE: TPUB ) shares tumbled 23 percent to $8.19 after the company lowered its FY15 revenue and adjusted EBITDA outlook. \nShares of Can Fite Biopharma Ltd (ADR) (NYSE: CANF ) were down 10 percent to $4.41 following announcement of a $9 million registered direct offering. \nImmunoGen, Inc. (NASDAQ: IMGN ) was down, falling 10 percent to $13.20. Morgan Stanley downgraded Immunogen from Equal-weight to Underweight and lowered the price target from $10.00 to $9.00. \nCommodities \nIn commodity news, oil traded up 2.57 percent to $45.83, while gold traded down 0.49 percent to $1,132.20. \nSilver traded down 0.12 percent Monday to $15.15, while copper rose 0.59 percent to $2.40. \nEurozone \nEuropean shares were higher today. The eurozone\u2019s STOXX 600 jumped 1.14 percent, the Spanish Ibex Index rose 0.32 percent, while Italy\u2019s FTSE MIB Index climbed 1.02 percent. Meanwhile, the German DAX gained 0.31 percent, and the French CAC 40 jumped 1.29 percent, while U.K. shares rose 0.76 percent. \nEconomics \nSales of existing U.S. homes declined 4.8 percent to an annual pace of 5.31 million in August. However, economists were projecting sales to decline to a rate of 5.52 million. \nSee more from Benzinga\n\n    The day before the article was published, the stock price of Lennar Corporation was 49.03553009033203 and the day after the article was published, the stock price of Lennar Corporation was ",
 "expected": "47.334171295166016",
 "date": "2015-09-22",
 "ticker": "LEN",
 "company": "Lennar Corporation"
}